000 01598 a2200481 4500
005 20250516234706.0
264 0 _c20150915
008 201509s 0 0 eng d
022 _a1941-837X
024 7 _a10.3111/13696998.2014.971158
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShingler, S
245 0 0 _aUtilities for treatment-related adverse events in type 2 diabetes.
_h[electronic resource]
260 _bJournal of medical economics
_cJan 2015
300 _a45-55 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aComorbidity
650 0 4 _aDiabetes Mellitus, Type 2
_xcomplications
650 0 4 _aFemale
650 0 4 _aGastrointestinal Diseases
_xchemically induced
650 0 4 _aHealth Status
650 0 4 _aHumans
650 0 4 _aHypoglycemia
_xchemically induced
650 0 4 _aHypoglycemic Agents
_xadverse effects
650 0 4 _aHypovolemia
_xchemically induced
650 0 4 _aInterviews as Topic
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMycoses
_xchemically induced
650 0 4 _aQuality of Life
650 0 4 _aSocioeconomic Factors
650 0 4 _aUnited Kingdom
650 0 4 _aUrinary Tract Infections
_xchemically induced
700 1 _aFordham, B
700 1 _aEvans, M
700 1 _aSchroeder, M
700 1 _aThompson, G
700 1 _aDewilde, S
700 1 _aLloyd, A J
773 0 _tJournal of medical economics
_gvol. 18
_gno. 1
_gp. 45-55
856 4 0 _uhttps://doi.org/10.3111/13696998.2014.971158
_zAvailable from publisher's website
999 _c24233017
_d24233017